Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9791806 | 0.84 | CYP1A2 (0.47) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL27629506 | 0.84 | CYP1A2 (0.47) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL9183887 | 0.81 | NR1I2 (0.60) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL9183882 | 0.81 | NR1I2 (0.60) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL15537560 | 0.81 | ALDH1A1 (0.57) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL11467654 | 0.80 | ADORA3 (0.70) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL11467652 | 0.80 | ADORA3 (0.70) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL16994601 | 0.80 | ADORA3 (0.70) | NR1I2PGRADORA3PTGS2PDE4D | |
| Succinic Acid Diethyl Ester SCHEMBL28853161 | 0.80 | GAA (0.63) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL11630175 | 0.79 | GAA (0.46) | NR1I2PGRADORA3PTGS2PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996022766-A1 | SULFATED NONIONIC BLOCK COPOLYMER SURFACTANTS AS STABILIZER COATINGS FOR NANOPARTICLE COMPOSITIONS | NANOSYSTEMS L.L.C. (US) | 1996-08-01 | — | — | WO | claimed |
| US-7928222-B2 | Porphyrin compound, process for producing porphyrin compound, three-dimensional optical recording material, and three-dimensional optical recording medium | National University Corporation NARA Institute of Science and Technology (JP) | 2011-04-19 | — | — | US | disclosed |
| US-20070224529-A1 | Porphyrin compound, process for producing porphyrin compound, three-dimensional optical recording material, and three-dimensional optical recording medium | National University Corporation NARA Institute of Science and Technology (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1126884-A2 | RADIODENSE COMPOSITIONS | THE GENERAL HOSPITAL CORPORATION (US) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000025829-A2 | RADIODENSE COMPOSITIONS | THE GENERAL HOSPITAL CORPORATION (US) | 2000-05-11 | — | — | WO | disclosed |
| WO-1998048847-A1 | NANOPARTICLE COMPOSITION CONTAINING IODINATED X-RAY CONTRAST AGENT AS STABILIZER FOR THERMAL STERILIZATION | NYCOMED IMAGING AS (NO) | 1998-11-05 | — | — | WO | disclosed |
| WO-1996022766-A1 | SULFATED NONIONIC BLOCK COPOLYMER SURFACTANTS AS STABILIZER COATINGS FOR NANOPARTICLE COMPOSITIONS | NANOSYSTEMS L.L.C. (US) | 1996-08-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070224529-A1 | Porphyrin compound, process for producing porphyrin compound, three-dimensional optical recording material, and three-dimensional optical recording medium | PPOX, PNMT, PAH | NR1I2 1686/4885PGR 1993/4885ADORA3 2621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.